While Gregory Bolan can currently be found at Avondale Partners, LLC, a boutique investment banking and asset management firm in Nashville, Tennessee. He serves as a Senior Research Analyst covering Healthcare IT and Pharmaceutical Services at this time, but his entire decade-plus-long career has been focused primarily on the healthcare and targeted middle market sectors.
Over the years, Gregory Bolan has been working to improve his skills as researcher in the financial field. It is that experience that makes the difference and informs every investment decision he makes. His experience is very strong. Before Avondale, Greg was with with Sterne Agee as their Managing Director of Healthcare Equity Research. Working in that firm’s Nashville office, he focused primarily on pharmaceutical companies and he received a lot of recognition as a result, having been recognized by Starmine as a “Number 1 Stock Picker” for Life Science Tools & Services in 2014 and as the “Best Up & Comer” as part of Institutional Investor’s All-American Research Team Survey in 2010. Greg also helped to build an extremely skilled and knowledgeable team of healthcare analysts to examine such sub-sectors as Specialty Pharma, Managed Care and Medical Devices & Diagnostics.
During Greg Bolan’s career, he has also spent a lot of time as a Director of Healthcare Equity Research for the Nashville office of Wells Fargo Securities and he was a Senior Associate of Healthcare Equity Research with Jefferies & Company in Nashville. In addition, he served as an healthcare associate at FNY GMG Capital in New York City. During his time at all of these firms, his primary focus was on the buy side of the healthcare industry.